Panacea Biotec Q2 Results

  • BSE: 531349
  • NSE: PANACEABIO
  • ISIN: INE922B01023
  • Sector: Biotechnology & Drugs
BSE
421.4512.00 (2.93%)
Volume15.20 K
Updated: Mon 25 Nov, 2024 | 15:52:39
NSE
426.216.20 (3.95%)
Volume2.42 L
Updated: Mon 25 Nov, 2024 | 15:31:25
Today: 404.00
428.00
52-Wk: 112.70
420.00

Q2 Results Highlights

  • Total Income
    ₹147.35 Cr.
    (27.33%)
  • Operating Profit
    ₹1.09 Cr.
    (NA%)
  • Profit After Tax
    ₹4.80 Cr.
    (NA%)
  • Operating Margin
    0.74%
    (NA%)
Note: Comparison is on YoY basis

Quarterly - Panacea Biotec Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 147.35129.19-%143.02-%
Selling/ General/ Admin Expenses Total 43.4435.97-%37.52-%
Depreciation/ Amortization 8.689.48-%9.31-%
Other Operating Expenses Total 53.7248.67-%50.87-%
Total Operating Expense 146.26121.24-%153.12-%
Operating Income 1.097.95-%-10.10-%
Net Income Before Taxes 4.7613.03-%-7.78-%
Net Income 4.8010.98-%-8.29-%
Diluted Normalized EPS 0.33-1.15-%-1.64-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts